Idiopathic pulmonary fibrosis: A new era, new challenges

被引：0
作者：
Cottin, V. [1 ]
机构：
[1] Univ Lyon 1, Hop Lyon, Hop Louis Pradel, Ctr Natl Reference Malad Pulmonaires Rares,Serv P, F-69677 Lyon, France
来源：
REVUE DES MALADIES RESPIRATOIRES | 2014年 / 31卷 / 07期
关键词：
ACETYLCYSTEINE; PIRFENIDONE; DIAGNOSIS; EFFICACY; TRIALS;
D O I：
10.1016/j.rmr.2014.07.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：583 / 586
页数：4
相关论文
共 50 条
  • [1] A new era of drug therapy for idiopathic pulmonary fibrosis
    Crooks, Michael G.
    Hart, Simon P.
    LANCET RESPIRATORY MEDICINE, 2014, 2 (12) : 964 - 966
  • [2] Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis
    Selvaggio, Anna S.
    Noble, Paul W.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 487 - 495
  • [3] Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!
    Crestani, B.
    REVUE DE MEDECINE INTERNE, 2015, 36 (11): : 719 - 721
  • [4] Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
    Robalo-Cordeiro, C.
    Campos, P.
    Carvalho, L.
    Borba, A.
    Clemente, S.
    Freitas, S.
    Furtado, S.
    Jesus, J. M.
    Leal, C.
    Marques, A.
    Melo, N.
    Souto-Moura, C.
    Neves, S.
    Sousa, V.
    Santos, A.
    Morais, A.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2017, 23 (05) : 287 - 293
  • [5] A New Hope for Idiopathic Pulmonary Fibrosis
    Hunninghake, Gary M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22) : 2142 - 2143
  • [6] Practical Issues and Challenges in Idiopathic Pulmonary Fibrosis
    Cottin, Vincent
    Camus, Philippe
    RESPIRATION, 2013, 86 (01) : 1 - 4
  • [7] Update on New Treatments for Idiopathic Pulmonary Fibrosis
    Jeremy R. DeGrado
    James F. Gilmore
    Current Emergency and Hospital Medicine Reports, 2015, 3 (3) : 134 - 138
  • [8] Update on New Treatments for Idiopathic Pulmonary Fibrosis
    DeGrado, Jeremy R.
    Gilmore, James F.
    CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2015, 3 (03): : 134 - 138
  • [9] The safety of new drug treatments for idiopathic pulmonary fibrosis
    Fletcher, Sophie
    Jones, Mark G.
    Spinks, Katherine
    Sgalla, Giacomo
    Marshall, Ben G.
    Limbrey, Rachel
    Richeldi, Luca
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1483 - 1489
  • [10] Ability of Periostin as a New Biomarker of Idiopathic Pulmonary Fibrosis
    Okamoto, Masaki
    Izuhara, Kenji
    Ohta, Shoichiro
    Ono, Junya
    Hoshino, Tomoaki
    PERIOSTIN, 2019, 1132 : 79 - 87
12345